Protective Effects of Reduced Beta 2 Glycoprotein I on Liver Injury in Streptozotocin (STZ)-Diabetic Rats by Activation of AMP-Activated Protein Kinase.
Ontology highlight
ABSTRACT: BACKGROUND Protective effects of reduced beta 2 glycoprotein I (Rb2GPI) against vascular injury of diabetes mellitus have been extensively investigated. However, the effects of Rb2GPI on liver injury in diabetic animals have not been reported. MATERIAL AND METHODS A diabetic rat model of was produced by systemic injection of streptozotocin (STZ). Rats were divided into a normal control group, a model group, and an Rb2GPI treatment group (N=6 in each group). After treatments, blood serum and liver tissue were collected to test the protection of Rb2GPI. AMP-activated protein kinase (AMPK) was detected by immunohistochemistry and Western blotting. RESULTS Our results revealed that R?2GPI reduced blood glucose, serum creatinine, and urea nitrogen levels, as well as serum inflammation cytokines, including interleukin (IL)-6, tumor necrosis factor (TNF)-? and C-reactive protein in the diabetic rats. Importantly, R?2GPI prevented liver injury in the diabetic rats as confirmed by hematoxylin-eosin (H&E) staining, alanine transaminase, aspartate transaminase, and gamma-glutamyl transferase. Reactive oxygen species (ROS) were promoted by diabetic modeling and were attenuated by R?2GPI administration. Moreover, R?2GPI significantly reduced liver catalase, malondialdehyde, and superoxide dismutase levels in the diabetic rats. R?2GPI reduced liver glycolipid storage in STZ diabetic rats. Both immunohistochemistry and Western blotting demonstrated that R?2GPI promoted AMPK phosphorylation in the diabetic rats. CONCLUSIONS Our data proved that R?2GPI prevented liver injury in diabetic rats, likely through activating the AMPK signaling pathway.
SUBMITTER: Zhang JY
PROVIDER: S-EPMC6210935 | biostudies-literature | 2018 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA